209 related articles for article (PubMed ID: 8340921)
21. In vitro and in vivo effects of UP 269-6, a new potent orally active nonpeptide angiotensin II receptor antagonist, on vascular smooth muscle cell proliferation.
Virone-Oddos A; Desangle V; Provost D; Cazes M; Caussade F; Cloarec A
Br J Pharmacol; 1997 Feb; 120(3):488-94. PubMed ID: 9031754
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological profile of a novel nonpeptide angiotensin II subtype 1 receptor antagonist, TCV-116.
Nishikawa K; Inada Y; Shibouta Y; Wada T; Ojima M; Kubo K; Naka T
Blood Press Suppl; 1994; 5():7-14. PubMed ID: 7889205
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological profile of GR117289 in vitro: a novel, potent and specific non-peptide angiotensin AT1 receptor antagonist.
Robertson MJ; Barnes JC; Drew GM; Clark KL; Marshall FH; Michel A; Middlemiss D; Ross BC; Scopes D; Dowle MD
Br J Pharmacol; 1992 Dec; 107(4):1173-80. PubMed ID: 1467838
[TBL] [Abstract][Full Text] [Related]
24. General pharmacological properties of the new angiotensin II receptor antagonist (+/-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl) biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate. Part I: Effects on central nervous system and other properties.
Kito G; Morimoto S; Shiomi M
Arzneimittelforschung; 1996 Jun; 46(6):572-9. PubMed ID: 8767346
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological profile of TH-142177, a novel orally active AT1-receptor antagonist.
Nozawa Y; Haruno A; Oda N; Yamasaki Y; Matsuura N; Miyake H; Yamada S; Kimura R
Fundam Clin Pharmacol; 1997; 11(5):395-401. PubMed ID: 9342592
[TBL] [Abstract][Full Text] [Related]
26. Nonpeptide angiotensin II receptor antagonists: insurmountable angiotensin II antagonism of EXP3892 is reversed by the surmountable antagonist DuP 753.
Wong PC; Timmermans PB
J Pharmacol Exp Ther; 1991 Jul; 258(1):49-57. PubMed ID: 2072311
[TBL] [Abstract][Full Text] [Related]
27. Non-peptide angiotensin II receptor antagonists. 2. Design, synthesis, and biological activity of N-substituted (phenylamino)phenylacetic acids and acyl sulfonamides.
Dhanoa DS; Bagley SW; Chang RS; Lotti VJ; Chen TB; Kivlighn SD; Zingaro GJ; Siegl PK; Patchett AA; Greenlee WJ
J Med Chem; 1993 Dec; 36(26):4239-49. PubMed ID: 8277506
[TBL] [Abstract][Full Text] [Related]
28. Lack of a centrally-mediated antihypertensive effect following acute or chronic central treatment with AT1-receptor antagonists in spontaneously hypertensive rats.
Bunting MW; Widdop RE
Br J Pharmacol; 1995 Dec; 116(8):3181-90. PubMed ID: 8719794
[TBL] [Abstract][Full Text] [Related]
29. Characterization of BIBS 39 and BIBS 222: two new nonpeptide angiotensin II receptor antagonists.
Zhang J; Entzeroth M; Wienen W; Van Meel JC
Eur J Pharmacol; 1992 Jul; 218(1):35-41. PubMed ID: 1397034
[TBL] [Abstract][Full Text] [Related]
30. A new series of imidazolones: highly specific and potent nonpeptide AT1 angiotensin II receptor antagonists.
Bernhart CA; Perreaut PM; Ferrari BP; Muneaux YA; Assens JL; Clément J; Haudricourt F; Muneaux CF; Taillades JE; Vignal MA
J Med Chem; 1993 Oct; 36(22):3371-80. PubMed ID: 8230127
[TBL] [Abstract][Full Text] [Related]
31. Studies on nonpeptide angiotensin II receptor antagonists. IV. Synthesis and biological evaluation of 4-acrylamide-1H-imidazole derivatives.
Okazaki T; Watanabe T; Kikuchi K; Suga A; Shibasaki M; Fujimori A; Inagaki O; Yanagisawa I
Chem Pharm Bull (Tokyo); 1998 Jun; 46(6):973-81. PubMed ID: 9658576
[TBL] [Abstract][Full Text] [Related]
32. Pharmacology of SC-52458, an orally active, nonpeptide angiotensin AT1 receptor antagonist.
Olins GM; Corpus VM; Chen ST; McMahon EG; Palomo MA; McGraw DE; Smits GJ; Null CL; Brown MA; Bittner SE
J Cardiovasc Pharmacol; 1993 Oct; 22(4):617-25. PubMed ID: 7505365
[TBL] [Abstract][Full Text] [Related]
33. Kinetic studies on the interaction of nonlabeled antagonists with the angiotensin II receptor.
Hara M; Kiyama R; Nakajima S; Kawabata T; Kawakami M; Ohtani K; Itazaki K; Fujishita T; Fujimoto M
Eur J Pharmacol; 1995 Apr; 289(2):267-73. PubMed ID: 7621900
[TBL] [Abstract][Full Text] [Related]
34. In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist.
Siegl PK; Chang RS; Mantlo NB; Chakravarty PK; Ondeyka DL; Greenlee WJ; Patchett AA; Sweet CS; Lotti VJ
J Pharmacol Exp Ther; 1992 Jul; 262(1):139-44. PubMed ID: 1625193
[TBL] [Abstract][Full Text] [Related]
35. Pharmacologic profiles of KRH-594, a novel nonpeptide angiotensin II-receptor antagonist.
Tamura K; Okuhira M; Amano H; Inokuma K; Hirata T; Mikoshiba I; Hashimoto K
J Cardiovasc Pharmacol; 1997 Nov; 30(5):607-15. PubMed ID: 9388043
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological characterization of the novel nonpeptide angiotensin II receptor antagonist, BIBR 277.
Wienen W; Hauel N; Van Meel JC; Narr B; Ries U; Entzeroth M
Br J Pharmacol; 1993 Sep; 110(1):245-52. PubMed ID: 8220885
[TBL] [Abstract][Full Text] [Related]
37. In vivo pharmacological characterization of UP 269-6, a novel nonpeptide angiotensin II receptor antagonist.
Cazes M; Provost D; Versigny A; Cloarec A
Eur J Pharmacol; 1995 Sep; 284(1-2):157-70. PubMed ID: 8549620
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and structure-activity relationship of a new series of potent AT1 selective angiotensin II receptor antagonists: 5-(biphenyl-4-ylmethyl)pyrazoles.
Almansa C; Gómez LA; Cavalcanti FL; de Arriba AF; García-Rafanell J; Forn J
J Med Chem; 1997 Feb; 40(4):547-58. PubMed ID: 9046346
[TBL] [Abstract][Full Text] [Related]
39. BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174.
Dickinson KE; Cohen RB; Skwish S; Delaney CL; Serafino RP; Poss MA; Gu Z; Ryono DE; Moreland S; Powell JR
Br J Pharmacol; 1994 Sep; 113(1):179-89. PubMed ID: 7812609
[TBL] [Abstract][Full Text] [Related]
40. DuP 532: a second generation of nonpeptide angiotensin II receptor antagonists.
Chiu AT; Carini DJ; Duncia JV; Leung KH; McCall DE; Price WA; Wong PC; Smith RD; Wexler RR; Timmermans PB
Biochem Biophys Res Commun; 1991 May; 177(1):209-17. PubMed ID: 2043107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
